Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $2.057B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZYME | ZYMEWORKS INC | 22,970,388 | $600M | 29.2% | — | — | COM | 98985Y108 |
| ANAB | ANAPTYSBIO INC | 7,880,094 | $532M | 25.9% | — | — | COM | 032724106 |
| AKTS | AKTIS ONCOLOGY INC | 4,824,469 | $155M | 7.6% | — | — | COM | 01021M104 |
| CGON | CG ONCOLOGY INC | 1,494,300 | $106M | 5.2% | — | — | COM | 156944100 |
| ETON | ETON PHARMACEUTICALS INC | 2,171,938 | $78.62M | 3.8% | — | — | COM | 29772L108 |
| CRSP | CRISPR THERAPEUTICS AG | 1,389,276 | $75.77M | 3.7% | — | — | NAMEN AKT | H17182108 |
| ORIC | ORIC PHARMACEUTICALS INC | 6,728,116 | $72.87M | 3.5% | — | — | COM | 68622P109 |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS | 3,174,519 | $63.87M | 3.1% | — | — | ORD SHS ADDED | 337185102 |
| GLPG | LAKEFRONT BIOTHERAPEUTICS NV | 1,667,119 | $49.98M | 2.4% | — | — | SPON ADR | 36315X101 |
| NGNE | NEUROGENE INC | 1,271,342 | $39.98M | 1.9% | — | — | COM | 64135M105 |
| CGON | CG ONCOLOGY INC | 561,500 | $39.89M | 1.9% | — | — | Call | 156944100 |
| STOK | STOKE THERAPEUTICS INC | 735,000 | $24.05M | 1.2% | — | — | COM | 86150R107 |
| FULC | FULCRUM THERAPEUTICS INC | 6,549,866 | $23.97M | 1.2% | — | — | COM | 359616109 |
| LEGN | LEGEND BIOTECH CORP | 800,000 | $23.1M | 1.1% | — | — | SPONSORED ADS | 52490G102 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $21.51M | 1.0% | — | — | COM NEW | 107924102 |
| MBX | MBX BIOSCIENCES INC | 388,500 | $21.45M | 1.0% | — | — | COM | 55287L101 |
| ZBIO | ZENAS BIOPHARMA INC | 789,500 | $20.04M | 1.0% | — | — | COM | 98937L105 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 1,552,000 | $17.82M | 0.9% | — | — | COM NEW | 046513206 |
| RLAY | RELAY THERAPEUTICS INC | 697,948 | $13.06M | 0.6% | — | — | COM | 75943R102 |
| AURA | AURA BIOSCIENCES INC | 1,666,667 | $11.83M | 0.6% | — | — | COM | 05153U107 |
| ODTX | ODYSSEY THERAPEUTICS INC | 555,555 | $10.39M | 0.5% | — | — | COMMON STOCK ADDED | 67613T104 |
| EIKN | EIKON THERAPEUTICS INC | 732,606 | $9.561M | 0.5% | — | — | COM | 282564103 |
| PHVS | PHARVARIS N V | 235,000 | $8.126M | 0.4% | — | — | COM | N69605108 |
| ZURA | ZURA BIO LTD | 1,179,715 | $6.96M | 0.3% | — | — | CLASS A ORD SHS | G9TY5A101 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 625,000 | $6.781M | 0.3% | — | — | COM | 71722W107 |
| NRIX | NURIX THERAPEUTICS INC | 270,000 | $6.55M | 0.3% | — | — | COM | 67080M103 |
| ERAS | ERASCA INC | 330,000 | $6.046M | 0.3% | — | — | COM | 29479A108 |
| ELOX | ELOXX PHARMACEUTICALS INC | 400,000 | $5.552M | 0.3% | — | — | COM NEW ADDED | 29014R301 |
| AARD | AARDVARK THERAPEUTICS INC | 396,194 | $2.282M | 0.1% | — | — | COM | 002942100 |
| HLXC | HELIX ACQUISITION CORP III USD | 200,000 | $2.128M | 0.1% | — | — | CL A ORD SHS | G4444S107 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1,000,000 | $318K | 0.0% | — | — | SPON ADS | 589492107 |
| SRZNW | SURROZEN INC | 4,444 | $115K | 0.0% | — | — | *W EXP 08/01/203 | 86889P117 |
| AARD | AARDVARK THERAPEUTICS INC | 14,700 | $84,672 | 0.0% | — | — | Call | 002942100 |